Table of Contents

Executive Summary

1 Industry Overview of Asthma Drugs

• 1.1 Definition of Asthma Drugs
• 1.2 Asthma Drugs Segment by Type
  • 1.2.1 Global Asthma Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Quick-relief Medications (Rescue Medications)
  • 1.2.3 Medications for Allergy-induced Asthma
• 1.3 Asthma Drugs Segment by Applications
  • 1.3.1 Global Asthma Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Allergic Asthma
  • 1.3.3 Non-Allergic Asthma
• 1.4 Global Asthma Drugs Overall Market
  • 1.4.1 Global Asthma Drugs Revenue (2014-2025)
  • 1.4.2 Global Asthma Drugs Production (2014-2025)
  • 1.4.3 North America Asthma Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Asthma Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Asthma Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Asthma Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Asthma Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Asthma Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Asthma Drugs
• 2.3 Manufacturing Process Analysis of Asthma Drugs
• 2.4 Industry Chain Structure of Asthma Drugs

3 Development and Manufacturing Plants Analysis of Asthma Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Asthma Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Asthma Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Asthma Drugs Production and Capacity Analysis
• 4.2 Asthma Drugs Revenue Analysis
• 4.3 Asthma Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Asthma Drugs Regional Market Analysis

• 5.1 Asthma Drugs Production by Regions
  • 5.1.1 Global Asthma Drugs Production by Regions
  • 5.1.2 Global Asthma Drugs Revenue by Regions
• 5.2 Asthma Drugs Consumption by Regions
• 5.3 North America Asthma Drugs Market Analysis
  • 5.3.1 North America Asthma Drugs Production
  • 5.3.2 North America Asthma Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Asthma Drugs Import and Export
• 5.4 Europe Asthma Drugs Market Analysis
  • 5.4.1 Europe Asthma Drugs Production
  • 5.4.2 Europe Asthma Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Asthma Drugs Import and Export
• 5.5 China Asthma Drugs Market Analysis
  • 5.5.1 China Asthma Drugs Production
  • 5.5.2 China Asthma Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Asthma Drugs Import and Export
• 5.6 Japan Asthma Drugs Market Analysis
  • 5.6.1 Japan Asthma Drugs Production
  • 5.6.2 Japan Asthma Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Asthma Drugs Import and Export
• 5.7 Southeast Asia Asthma Drugs Market Analysis
  • 5.7.1 Southeast Asia Asthma Drugs Production
  • 5.7.2 Southeast Asia Asthma Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Asthma Drugs Import and Export
• 5.8 India Asthma Drugs Market Analysis
  • 5.8.1 India Asthma Drugs Production
  • 5.8.2 India Asthma Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Asthma Drugs Import and Export

6 Asthma Drugs Segment Market Analysis (by Type)

• 6.1 Global Asthma Drugs Production by Type
• 6.2 Global Asthma Drugs Revenue by Type
• 6.3 Asthma Drugs Price by Type

7 Asthma Drugs Segment Market Analysis (by Application)

• 7.1 Global Asthma Drugs Consumption by Application
• 7.2 Global Asthma Drugs Consumption Market Share by Application (2014-2019)

8 Asthma Drugs Major Manufacturers Analysis

• 8.1 Pfizer
  • 8.1.1 Pfizer Asthma Drugs Production Sites and Area Served
  • 8.1.2 Pfizer Product Introduction, Application and Specification
  • 8.1.3 Pfizer Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 GlaxoSmithKline
  • 8.2.1 GlaxoSmithKline Asthma Drugs Production Sites and Area Served
  • 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.2.3 GlaxoSmithKline Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Novartis
  • 8.3.1 Novartis Asthma Drugs Production Sites and Area Served
  • 8.3.2 Novartis Product Introduction, Application and Specification
  • 8.3.3 Novartis Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Merck
  • 8.4.1 Merck Asthma Drugs Production Sites and Area Served
  • 8.4.2 Merck Product Introduction, Application and Specification
  • 8.4.3 Merck Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Boehringer Ingelheim
  • 8.5.1 Boehringer Ingelheim Asthma Drugs Production Sites and Area Served
  • 8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
  • 8.5.3 Boehringer Ingelheim Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 AstraZeneca
  • 8.6.1 AstraZeneca Asthma Drugs Production Sites and Area Served
  • 8.6.2 AstraZeneca Product Introduction, Application and Specification
  • 8.6.3 AstraZeneca Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Roche
  • 8.7.1 Roche Asthma Drugs Production Sites and Area Served
  • 8.7.2 Roche Product Introduction, Application and Specification
  • 8.7.3 Roche Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Teva Pharmaceutical
  • 8.8.1 Teva Pharmaceutical Asthma Drugs Production Sites and Area Served
  • 8.8.2 Teva Pharmaceutical Product Introduction, Application and Specification
  • 8.8.3 Teva Pharmaceutical Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Vectura Group
  • 8.9.1 Vectura Group Asthma Drugs Production Sites and Area Served
  • 8.9.2 Vectura Group Product Introduction, Application and Specification
  • 8.9.3 Vectura Group Asthma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Asthma Drugs Market

• 9.1 Global Asthma Drugs Market Trend Analysis
  • 9.1.1 Global Asthma Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Asthma Drugs Regional Market Trend
  • 9.2.1 North America Asthma Drugs Forecast 2019-2025
  • 9.2.2 Europe Asthma Drugs Forecast 2019-2025
  • 9.2.3 China Asthma Drugs Forecast 2019-2025
  • 9.2.4 Japan Asthma Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Asthma Drugs Forecast 2019-2025
  • 9.2.6 India Asthma Drugs Forecast 2019-2025
• 9.3 Asthma Drugs Market Trend (Product Type)
• 9.4 Asthma Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Asthma Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.

The global Asthma Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Asthma Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Asthma Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Asthma Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Asthma Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Segment by Application
Allergic Asthma
Non-Allergic Asthma